HIV-1 adaptation to NK-cell-mediated immune pressure

Nature. 2011 Aug 3;476(7358):96-100. doi: 10.1038/nature10237.

Abstract

Natural killer (NK) cells have an important role in the control of viral infections, recognizing virally infected cells through a variety of activating and inhibitory receptors. Epidemiological and functional studies have recently suggested that NK cells can also contribute to the control of HIV-1 infection through recognition of virally infected cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs). However, it remains unknown whether NK cells can directly mediate antiviral immune pressure in vivo in humans. Here we describe KIR-associated amino-acid polymorphisms in the HIV-1 sequence of chronically infected individuals, on a population level. We show that these KIR-associated HIV-1 sequence polymorphisms can enhance the binding of inhibitory KIRs to HIV-1-infected CD4(+) T cells, and reduce the antiviral activity of KIR-positive NK cells. These data demonstrate that KIR-positive NK cells can place immunological pressure on HIV-1, and that the virus can evade such NK-cell-mediated immune pressure by selecting for sequence polymorphisms, as was previously described for virus-specific T cells and neutralizing antibodies. NK cells might therefore have a previously underappreciated role in contributing to viral evolution.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological / genetics
  • Adaptation, Physiological / immunology*
  • Antibodies, Neutralizing / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • Decision Trees
  • Evolution, Molecular*
  • Genotype
  • HIV Infections / immunology*
  • HIV Infections / virology*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • HIV-1 / physiology
  • Host-Pathogen Interactions / immunology
  • Human Immunodeficiency Virus Proteins / genetics
  • Human Immunodeficiency Virus Proteins / immunology
  • Human Immunodeficiency Virus Proteins / metabolism
  • Humans
  • Immune Evasion / immunology*
  • Killer Cells, Natural / immunology*
  • Polymorphism, Genetic
  • Receptors, KIR / deficiency
  • Receptors, KIR / genetics
  • Receptors, KIR / immunology
  • Receptors, KIR / metabolism
  • Receptors, KIR2DL2 / chemistry
  • Receptors, KIR2DL2 / deficiency
  • Receptors, KIR2DL2 / genetics
  • Receptors, KIR2DL2 / immunology
  • Viral Regulatory and Accessory Proteins / genetics
  • Viral Regulatory and Accessory Proteins / immunology
  • Viral Regulatory and Accessory Proteins / metabolism
  • Virus Replication
  • env Gene Products, Human Immunodeficiency Virus / genetics
  • env Gene Products, Human Immunodeficiency Virus / immunology
  • env Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • Antibodies, Neutralizing
  • Human Immunodeficiency Virus Proteins
  • KIR2DL2 protein, human
  • Receptors, KIR
  • Receptors, KIR2DL2
  • Viral Regulatory and Accessory Proteins
  • env Gene Products, Human Immunodeficiency Virus
  • vpu protein, Human immunodeficiency virus 1